Delivery Order SPE2DR25D3017-SPE2DR26F3FA1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,616.17 by the Defense Logistics Agency on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by November 26, 2025. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $44,901.48 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $9,635.90 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is effective through December 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,848.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, and represents a non-set-aside, competitively awarded procurement. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,591.89 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $7,387.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Arimidex 1 mg tablets, with a completion date of December 9, 2025. This is a non-set-aside contract issued competitively to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader contract vehicle with the Defense Logistics Agency. This delivery order is a...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- The Defense Logistics Agency awarded a delivery order valued at $5,731.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3FA1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $59,781.43 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of December 23, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio provided to the Defense Health Agency and other federal healthcare entities. The company's IDC with DLA Troop Support Medical functions as a global pharmaceutical support vehicle enabling the supply of a wide range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The award reflects the company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement processes, with delivery to be performed at the company's corporate office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.8k | 12/21/25 |